We are live on
!
Find out more
RMA
Roffman Miller Associates Portfolio holdings
AUM
$1.91B
1-Year Est. Return
28.29%
This Fund
S&P 500
This Quarter
Est. Return
+3.59%
1 Year Est. Return
+28.29%
3 Year Est. Return
+68.87%
5 Year Est. Return
+84.92%
10 Year Est. Return
+298.67%
AUM
$610M
AUM Growth
+$26.4M
(+4.5%)
Cap. Flow
+$6.79M
Cap. Flow
% of AUM
1.11%
Top 10 Holdings %
Top 10 Hldgs %
31.14%
Holding
67
New
1
Increased
47
Reduced
15
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Under Armour Class C
UA
|
+$8.13M |
| 2 |
CVS Health
CVS
|
+$3.33M |
| 3 |
Apple
AAPL
|
+$2.79M |
| 4 |
Microsoft
MSFT
|
+$1.12M |
| 5 |
JPMorgan Chase
JPM
|
+$1.05M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DD
Du Pont De Nemours E I
DD
|
+$13.7M |
| 2 |
Under Armour
UAA
|
+$7.96M |
| 3 |
Bath & Body Works
BBWI
|
+$2.3M |
| 4 |
EMC
EMC CORPORATION
EMC
|
+$1.08M |
| 5 |
Johnson & Johnson
JNJ
|
+$647K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 16.79% |
| 2 | Consumer Staples | 16.23% |
| 3 | Technology | 14.52% |
| 4 | Consumer Discretionary | 13.75% |
| 5 | Healthcare | 11.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Southern Company
SO
$107B
| $813K | 0.13% |
15,157
-150
| -1% | -$7.54K |
|
52
Berkshire Hathaway Class B
BRK.B
$1.11T
| $748K | 0.12% |
5,163
-350
| -6% | -$50K |
|
53
Bristol-Myers Squibb
BMY
$134B
| $736K | 0.12% |
10,009
-94
| -0.9% | -$6.64K |
|
54
Cisco
CSCO
$457B
| $590K | 0.1% |
20,565
-323
| -2% | -$9.07K |
|
|
DD
55
DELISTED
Du Pont De Nemours E I
DD
| $577K | 0.09% |
8,900
-208,076
| -96% | -$13.7M |
|
56
Schwab US TIPS ETF
SCHP
$16.2B
| $557K | 0.09% |
19,716
-1,120
| -5% | -$31.1K |
|
57
Essential Utilities
WTRG
$11B
| $507K | 0.08% |
14,219
+120
| +0.9% | +$3.91K |
|
58
Pfizer
PFE
$143B
| $466K | 0.08% |
13,963
+2,823
| +25% | +$90.1K |
|
59
Oracle
ORCL
$409B
| $439K | 0.07% |
10,719
-384
| -3% | -$15.3K |
|
60
DuPont de Nemours
DD
$19.1B
| $420K | 0.07% |
3,335
+332
| +11% | +$43.7K |
|
61
GSK
GSK
$103B
| $391K | 0.06% |
7,210
+60
| +0.8% | +$3.16K |
|
62
Fortune Brands Innovations
FBIN
$6.22B
| $234K | 0.04% |
4,731
-396
| -8% | -$19.3K |
|
63
Pinnacle West Capital
PNW
$12.2B
| $231K | 0.04% |
2,845
-300
| -10% | -$22.4K |
|
|
64
Bath & Body Works
BBWI
$4.23B
| – | – |
-32,386
| Closed | -$2.3M |
|
65
Vanguard Short-Term Bond ETF
BSV
$44.6B
| – | – |
-2,799
| Closed | -$226K |
|
66
Walmart Inc
WMT
$881B
| – | – |
-11,451
| Closed | -$261K |
|
|
TIF
67
DELISTED
Tiffany & Co.
TIF
| – | – |
-8,382
| Closed | -$615K |
|
Similar funds
RIL
MC
BOH
6CM
QOP
IAN
RCAG
FTCM
Roffman Miller Associates's Q2 2016 Portfolio in Review
As of Q2 2016, Roffman Miller Associates held 67 positions worth $610M, up 4.5% from $583M the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Roffman Miller Associates's Q2 2016 filing shows 1 new, 47 increased, 15 reduced and 4 closed positions. Its largest new stake was Under Armour Class C: 220,405 shares worth $8.02M. The largest sale was Du Pont De Nemours E I, an estimated $13.7M.
By sector, the portfolio is most concentrated in Industrials at 17% of assets, up from 16% a quarter earlier, followed by Consumer Staples and Technology.
- Roffman Miller Associates's largest Q2 2016 buy was Under Armour Class C: 220,405 shares worth $8.02M.
- Roffman Miller Associates added most to CVS Health in Q2 2016, an estimated $3.33M increase.
- Roffman Miller Associates's biggest Q2 2016 reduction was Du Pont De Nemours E I, cutting an estimated $13.7M.
- Roffman Miller Associates fully exited Bath & Body Works in Q2 2016, selling an estimated $2.3M.
- Roffman Miller Associates's ten largest holdings make up 31% of its $610M portfolio in Q2 2016.
- Roffman Miller Associates opened 1 new position and closed 4 in Q2 2016.
- Roffman Miller Associates's portfolio value rose 4.5% quarter-over-quarter to $610M.
Based on Roffman Miller Associates's 13F filing for Q2 2016, filed 19 Jul 2016.